BRAF and hepatocellular carcinoma: NEIL3 may promote the migration, invasion, and stemness of HCC cells by activating the BRAF/MEK/ERK/TWIST pathway or by regulating the PI3K/Akt/mTOR signaling pathway (Lai et al., 2022; Wang et al., 2021).